Profile data is unavailable for this security.
About the company
Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.
- Revenue in AUD (TTM)26.97m
- Net income in AUD-5.55m
- Incorporated1977
- Employees90.00
- LocationMach7 Technologies LtdLevel 4, 100 Albert RoadMELBOURNE 3205AustraliaAUS
- Phone+61 39013-7348
- Fax+61 39645-4707
- Websitehttps://mach7t.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SDI Ltd | 109.61m | 8.04m | 93.90m | 300.00 | 11.68 | 1.05 | 7.61 | 0.8567 | 0.0676 | 0.0676 | 0.9221 | 0.7494 | 0.8449 | 1.69 | 6.22 | -- | 6.20 | 7.27 | 7.46 | 8.40 | 59.28 | 59.79 | 7.34 | 8.07 | 1.26 | 10.37 | 0.2318 | 51.85 | 13.35 | 7.67 | -3.09 | 4.50 | 52.58 | 5.39 |
| Imricor Medical Systems Inc | 928.18k | -34.12m | 98.39m | -- | -- | -- | -- | 106.00 | -0.2168 | -0.2168 | 0.0059 | -0.0781 | 0.0559 | 0.8749 | 2.38 | -- | -205.60 | -93.47 | -294.49 | -106.30 | -181.27 | -134.71 | -3,675.60 | -2,462.89 | 0.4944 | -3.64 | 15.92 | -- | -24.56 | -9.29 | -30.36 | -- | -10.82 | -- |
| Genetic Signatures Ltd | 16.49m | -18.04m | 136.16m | -- | -- | 3.36 | -- | 8.26 | -0.1245 | -0.1245 | 0.1136 | 0.2172 | 0.3366 | 1.06 | 5.25 | -- | -36.81 | -7.14 | -40.19 | -7.82 | 40.66 | 57.68 | -109.38 | -13.74 | 5.95 | -18,040.00 | 0.0003 | -- | -38.11 | 33.44 | -558.77 | -- | 73.20 | -- |
| ImpediMed Ltd | 10.47m | -19.42m | 153.76m | 76.00 | -- | 3.02 | -- | 14.68 | -0.0102 | -0.0102 | 0.0055 | 0.0252 | 0.1961 | 1.32 | 4.41 | 137,802.60 | -36.37 | -52.27 | -40.94 | -62.34 | 86.95 | 80.64 | -185.47 | -264.76 | 6.85 | -- | 0.0244 | -- | 7.36 | 27.87 | -3.26 | -- | 37.83 | -- |
| Cyclopharm Limited | 32.21m | -4.70m | 155.37m | 87.00 | -- | 4.19 | -- | 4.82 | -0.0508 | -0.0508 | 0.3476 | 0.3428 | 0.6748 | 1.11 | 4.13 | 370,173.10 | -9.85 | -12.60 | -11.92 | -14.94 | 68.15 | 70.20 | -14.60 | -25.47 | 2.32 | -18.40 | 0.1159 | -- | 11.22 | 15.50 | 28.90 | -- | -7.83 | -12.94 |
| Mach7 Technologies Ltd | 26.97m | -5.55m | 158.01m | 90.00 | -- | 2.90 | 73.01 | 5.86 | -0.0231 | -0.0231 | 0.1123 | 0.2256 | 0.3605 | -- | 3.21 | -- | -7.42 | -7.48 | -8.73 | -8.65 | 95.09 | 93.72 | -20.59 | -20.56 | -- | -2,605.17 | 0.0193 | -- | 10.97 | 28.30 | 74.85 | -- | 29.28 | -- |
| EMvision Medical Devices Ltd | 8.86m | -3.22m | 161.03m | -- | -- | 25.73 | -- | 18.17 | -0.0449 | -0.0449 | 0.1186 | 0.0733 | 0.7954 | -- | -- | -- | -28.95 | -67.20 | -45.25 | -79.38 | -- | -- | -36.40 | -175.99 | -- | -35.20 | 0.3424 | -- | 62.08 | 70.47 | 36.64 | -- | -- | -- |
| Aroa Biosurgery Ltd | 63.67m | -9.80m | 196.20m | 261.00 | -- | 2.24 | -- | 3.08 | -0.0285 | -0.0285 | 0.1852 | 0.2543 | 0.607 | 1.56 | 2.82 | -- | -9.34 | -10.37 | -10.11 | -12.52 | 85.39 | 80.63 | -15.39 | -20.31 | 6.40 | -- | 0.0726 | -- | 9.01 | 24.26 | -2,583.84 | -- | 33.65 | -- |
| 4DMedical Ltd | 1.03m | -30.83m | 230.92m | -- | -- | 2.53 | -- | 225.24 | -0.0882 | -0.0882 | 0.0029 | 0.2332 | 0.0098 | 0.092 | 0.1585 | -- | -29.47 | -43.96 | -39.07 | -57.58 | 95.00 | 32.30 | -3,007.64 | -2,704.36 | 1.79 | -- | 0.0476 | -- | -31.84 | -1.86 | -27.92 | -- | 2.46 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Australian Ethical Investments Ltd. (Investment Management)as of 27 May 2024 | 29.65m | 12.29% |
| Microequities Asset Management Pty Ltd. (Invt Mgmt)as of 14 Sep 2023 | 16.68m | 6.92% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 5.75m | 2.38% |
| DFA Australia Ltd.as of 30 Apr 2024 | 136.05k | 0.06% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 74.29k | 0.03% |
| Dimensional Fund Advisors Ltd.as of 09 May 2024 | 13.33k | 0.01% |
